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Abstract
The case presented highlights a common pre-analytical problem identified in the laboratory that was initially missed. It concerns a young, gene-
rally healthy adult patient with no significant medical history and no significant family history. They presented with common flu like symptoms to 
their primary care clinician who considered this was most likely a viral problem that would pass with time. The clinician, however, did some routine 
bloods to reassure the patient despite a lack of clinical indication. When the sample was analysed the sample was haemolysed with strikingly low 
calcium. This led to the patient being called into hospital for urgent repeat investigations, all of which turned out to be within normal ranges. On 
further investigation the original sample was found to be contaminated. This result would normally have been flagged but was missed due to the 
complication of haemolysis. 
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The case presented below highlights the conse-
quences for both patient and hospital when what 
is a relatively common pre-analytical problem pre-
sents in a more complex manner masking the fact 
that the results may be spurious. 
It has been well documented that phlebotomy is a 
crucial part of the pre-analytical process and that 
compliance with guidelines is often poor (1-3). This 
failure to comply with guidelines increases the 
chance of an error in the phlebotomy process 
which increases the risk of an error in the patient’s 
blood results and therefore potentially errors in 
patient care. 
One aspect of the phlebotomy process that is of-
ten incorrectly performed is the order of draw of 
the blood samples. The order of draw is a key step 
in the phlebotomy process and was originally es-
tablished to minimize the risk of additive carryover 
from one sample collection tube to the next. Re-
cent evidence around this has been conflicting 
and has shown that under ideal conditions it is no 
longer a problem (4,5). However there is good evi-
dence that sample contamination still occurs in 
the real world (6-12). The situation has been re-
viewed and the European Federation of Laborato-
ry Medicine’s Working Group for Pre-Analytical 
Phase (EFLM WG-PRE) made the recommendation 
to continue to recommend and order of draw (13). 
The other pre-analytical aspect that this case high-
lights is that of defensive medicine. This is the 
practice of ordering more tests than clinically re-
quired due to a fear of missing something and fac-
ing future litigation (14). The problem with this be-
haviour, other than cost implications, is that the 
clinician is increasing the probability of finding an 
abnormal result which may be of no clinical signifi-
cance but would result in unnecessary stress for 
the patient. 
From a patient perspective, erroneous results cre-
ate unnecessary stress and potential inconven-
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ience associated with coming to have repeat tests 
performed to confirm, or disprove the original re-
sult. From a hospital perspective there are costs 
associated with brining a patient in to be re-bled. 
These costs cover not only the extra consumables 
required to perform the tests, but also staff time 
and the fact that while this patient is being as-
sessed unnecessarily another patient is waiting. 
Case report
In this case a young, healthy adult patient with no 
significant medical history and no significant family 
history presented on a weekday morning with com-
mon influence like symptoms to their Primary Care 
facility. On examination the clinician suspected that 
this was most likely a viral problem that would pass 
naturally given time. The clinician, however, did 
some routine blood science tests to reassure the 
patient despite a lack of clinical indication. One se-
rum gel sample, one whole blood tube were col-
lected in the GP surgery. The samples were received 
by the laboratory the same afternoon and sorted 
for processing with other non-urgent work. All sam-
ples were analysed on an Abbott Architect c16000 
analyser (Abbott Diagnostics, Abbott Park, USA). 
When the sample was analysed in the early evening 
it was found to be haemolysed with strikingly low 
calcium as shown in Table 1. 
Given the critically low calcium result the labora-
tory contacted the out of hour’s clinician with the 
results in the early evening. The patient was con-
tacted later that evening and asked to come in to 
the emergency department to have their bloods 
checked. The patient was brought in by a family 
member and re-bled. For the repeat test only a se-
rum sample was collected. The results of this fol-
low up are shown in Table 1. When the second 
sample was analysed all the results which were 
previously abnormal were normal and, important-
ly, were much more in keeping with the clinical 
picture.
What happened? 
Given the changes in alkaline phosphatase (ALP) 
and calcium and the fact that an EDTA sample was 
also collected with the initial blood draw, potassi-
um-ethylenediaminetetraacetic acid (K-EDTA) con-
tamination is the most likely conclusion. The initial 
blood results were amended to reflect this.
Discussion
In the case presented here the patient’s initial sam-
ple clearly gave an erroneous result. This led to the 
patient being contacted and asked to come into 
hospital to have the result confirmed. The new re-
sults were normal and in keeping with the clinical 
picture. The patient was discharged. This is clearly 
a problem on three fronts:
•	 the patient was put under unnecessary stress 
and inconvenience due to concerns for their 
health
Parameter Initial values Repeated values Units Reference values
Haemolysis level 1.2 0.1 g/L N/A
Sodium 141 143 mmol/L 133–146
Potassium haemolysed 4.3 mmol/L 3.5–5.3
Creatinine 50 52 umol/L 44–80
Urea 3.1 3.4 mmol/L 2.5–7.8
Calcium 1.65 2.32 mmol/L 2.2–2.6
Albumin 42 41 g/L 35–50
Adjusted calcium 1.64 2.32 mmol/L 2.2–2.6
Alkaline phosphatase 29 65 IU/L 30–130
Table 1. Laboratory analyses
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•	 the cost of bringing a patient in to be re-bled 
was unnecessary and a waste of resources
•	 other patients were made to wait while this pa-
tient was seen unnecessarily.
In this sample the cause of the discrepancy was 
most likely K-EDTA contamination. The indicative 
factors in this case were the low calcium and low 
ALP. The calcium was reduced due to chelation by 
EDTA which is a chelator of divalent cations. Alka-
line phosphatase activity is likewise reduced be-
cause EDTA chelates magnesium and zinc which 
are cofactors for ALP. 
Routine practice in the laboratory involved is to in-
vestigate for K-EDTA contamination based on the 
potassium result. As the potassium result in this 
case was haemolysed this did not happen and the 
contamination was initially missed. Had the potas-
sium been over the 6.0 mmol/L trigger, and the re-
sult was not consistent with previous results, calci-
um would be requested to look for low levels. Sci-
entific and clinical judgment is then used to deter-
mine if the sample is contaminated (results hugely 
abnormal), has a possibility of contamination or is 
not contaminated. If contamination is confirmed 
results are removed from the patient record, 
whereas in suspected contamination a comment 
is added advising caution. Although calcium was 
requested in this instance, because there was no 
potassium the sample did not proceed down the 
investigative algorithm. 
There are other, scientifically better methods to in-
vestigate this. For example, the laboratory could 
have added on a zinc, magnesium and iron de-
pending on availability. Of these zinc is the most 
sensitive analyte as it has the highest affinity for 
EDTA (7). If the chosen markers were low this 
would provide further evidence of EDTA contami-
nation and the result could be phoned or reported 
with a comment suggesting possible contamina-
tion and the clinician, with the clinical knowledge 
of the patient, can then make a judgment that 
maybe this is a false result and doesn’t need ur-
gent checking. The gold standard for this scenario 
would be to have a test in place for the measure-
ment of EDTA directly to definitively rule contami-
nation in or out. This has been shown to pick up 
K-EDTA contamination that would otherwise have 
been missed via a reliance on the suspicion of lab-
oratory personnel (7-9,15). 
It is good practice for the laboratory to have proto-
cols in place to pick up and identify sources of in-
terference (13,16). Once these protocols are in 
place the laboratory must also have a document-
ed mechanism detailing how any rejected sam-
ples are going to be handled and how the request-
ors are going to be informed (17). In the case pre-
sented here results from samples with known con-
tamination are removed and the clinician in-
formed.
The other key point from this case is that if the re-
questing clinician felt that the patient’s symptoms 
were due to a virus requiring no treatment, then 
bloods should not have been taken in the first 
place. Laboratory testing should be used to aid 
clinical decisions only, not done as a matter of rou-
tine or to appear as if something proactive is be-
ing done. As can be seen in the case of this patient 
this then cascaded quite a cost implication and ul-
timately worried the patient rather than reassured. 
Tests should not be requested unless there is a val-
id reason. By definition 5% of blood results will be 
abnormal due to the method by which reference 
ranges are calculated and may then trigger follow 
up investigations. This is a growing problem in a 
climate of defensive medicine. Clinicians have fear 
of missing something and facing legal action and 
patients have access to so much information on-
line attend surgeries demanding blood tests (14). It 
is important that tests are requested in an evi-
dence based manner.
Key learning points
•	 Requesting unnecessary tests is a waste of re-
sources and can lead to unnecessary patient 
stress. 
•	 Statistically, 1 in 20 test results will fall outside a 
reference range but be perfectly normal for 
that patient. The laboratory should work with 
clinicians to reinforce this message.
•	 K-EDTA contamination is relatively common.
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•	 Contamination (or other interferences) should 
always be considered if a result does not fit 
with the clinical picture.
•	 Laboratories should have algorithms in place to 
try and identify contaminated samples.
•	 Clinicians should question results that do not fit 
with the clinical picture.
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